Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: Outcome after treatment in recently infected individuals

Antiviral Therapy

Volumn 5, Issue 1, 2000, Pages 7-14

  Balotta, Claudia ^a   Berlusconi, Alberto ^a   Pan, Angelo ^a   Violin, Michela ^a   Riva, Chiara ^a   Colombo, M Chiara ^a   Gori, Andrea ^a   Papagno, Laura ^a   Corvasce, Stefano ^a   Mazzucchelli, Renata ^a   Facchi, Guido ^a   Velleca, Rossella ^a   Saporetti, Giorgia ^a   Galli, Massimo ^a   Rusconi, Stefano ^a   Moroni, Mauro ^a  

^a CREMONA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INDINAVIR; NUCLEOSIDE ANALOG; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LYMPHOCYTE COUNT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROCONVERSION; TREATMENT OUTCOME; VIREMIA;

ANTI-HIV AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; GENE PRODUCTS, POL; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; INDINAVIR; MUTATION; PHENOTYPE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; RNA, VIRAL; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 17544366374     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Erice A, Mayers DL, Strike DG, Sannerud KJ, Mc Cutchan FE, Henry K & Balfour HH Jr. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. New England Journal of Medicine 1993; 328:1163-1165.
2. Sonnerburg A, Johansson B, Ayehunie S & Julander I. Transmission of zidovudine-resistant HIV-1. AIDS 1993; 7:1684-1685.
3. Conlon CP, Klenerman P, Edwards A, Larder BA & Phillips RE. Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance. Journal of Infectious Diseases 1994; 169:411-415.
4. Imrie A, Carr A, Duncombe C, Finlayson R, Vizzard J, Low M, Kaldor J, Penny R & Cooper DA. Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group. Journal of Infectious Diseases 1996; 174:195-198.
5. Frenkel LM, Wagner LE II, Demeter LM, Dewhurst S, Coombs RW, Murante BL & Reichman RC. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. Clinical Infectious Diseases 1995; 20:1321-1326.